Skip to main content
SpringerLink
Log in

Treatment for Dupuytren’s Disease: An Overview of Options

  • Chapter
  • First Online:
Dupuytren’s Disease and Related Hyperproliferative Disorders

Abstract

In this chapter, we present a systematic overview of the current treatment options for Dupuytren’s Disease based on high evidence level studies. Few publications on the effectiveness of these treatment options provide greater than level 4 evidence (expert opinion). Most hand surgeons practice limited fasciectomy. Dermofasciectomy is used for the treatment of recurrences due to the reported lower risk of recurrence. Percutaneous needle fasciotomy is a minimally invasive technique with good results in the short term for mild contractures, but has a high recurrence rate. Collagenase has been introduced to the American market, and short-term results are promising. Radiotherapy has been reported by some, but not all, to delay disease progression in early stages of the disease.

This chapter has previously been published in the Dutch Journal of Medicine as: van Rijssen AL, Werker PM (2009) Treatment of Dupuytren’s contracture; an overview of options [Article in Dutch] Ned Tijdschr Geneeskd. 153:A129. Translated and reproduced with permission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H (2004) An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease. J Hand Surg Br 29(5):427–430

    Article  PubMed  CAS  Google Scholar 

  • Adamietz B, Keilholz L, Grünert J, Sauer R (2001) Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years. Strahlenther Onkol 177:604–610

    Article  PubMed  CAS  Google Scholar 

  • Anthony SG, Lozano-Calderon SA, Simmons BP, Jupiter JB (2008) Gender ratio of Dupuytren’s disease in the modern U.S. population. Hand (N Y) 3(2):87–90

    Article  Google Scholar 

  • Armstrong JR, Hurren JS, Logan AM (2000) Dermofasciectomy in the management of Dupuytren’s disease. J Bone Joint Surg Br 82:90–94

    Article  PubMed  CAS  Google Scholar 

  • Badalamente MA, Hurst LC (2000) Enzyme injection as nonsurgical treatment of Dupuytren’s disease. J Hand Surg Am 25:629–636

    Article  PubMed  CAS  Google Scholar 

  • Badalamente MA, Hurst LC (2007) Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg Am 32:767–774

    Article  PubMed  Google Scholar 

  • Badalamente MA, Hurst LC, Hentz VR (2002) Collagen as a clinical target: nonoperative treatment of Dupuytren’s disease. J Hand Surg Am 27:788–798

    Article  PubMed  Google Scholar 

  • Baxter H, Schiller C, Johnson LH, Whiteside JH, Randall RE (1952) Cortisone therapy in Dupuytren’s contracture. Plast Reconstr Surg 9:261–273

    Article  CAS  Google Scholar 

  • Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE (2003) Genetic susceptibility to Dupuytren’s disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren’s disease. Br J Plast Surg 56:328–333

    Article  PubMed  CAS  Google Scholar 

  • Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R, Keilholz L (2010) Radiotherapy in early-stage Dupuytren’s contracture. Long-term results after 13 years. Strahlenther Onkol 186(2):82–90

    Article  PubMed  Google Scholar 

  • Chick LR, Lister GD (1991) Surgical alternatives in Dupuytren’s contracture. Hand Clin 7(4):715–719, discussion 721–2

    PubMed  CAS  Google Scholar 

  • Clibbon JJ, Logan AM (2001) Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal flexion contracture. J Hand Surg Br 26:360–361

    Article  PubMed  CAS  Google Scholar 

  • Descatha A (2012) Dupuytren’s Disease and Occupation. In: Dupuytren’s disease and related hyperproliferative disorders, pp 45–49

    Google Scholar 

  • Dolmans GH et al. (2011). Wnt signaling and Dupuytren’s disease. N Engl J Med 365(4):307–17

    Google Scholar 

  • Evans RB, Dell PC, Fiolkowski P (2002) A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren’s contracture. J Hand Ther 15:331–339

    Article  PubMed  Google Scholar 

  • Falter E, Herndl E, Mühlbauer W (1991) Dupuytren’s contracture. When operate? conservative preliminary treatment? Fortschr Med 9:223–226

    Google Scholar 

  • Foucher G, Cornil CH, Lenoble E (1992) ‘Open palm’ technique in Dupuytren’s disease. Postoperative complications and results after more than 5 years. Chirurgie 118:189–194

    PubMed  CAS  Google Scholar 

  • Gudmundsson KG, Arngrimsson R, Sigfusson N et al (2000) Epidemiology of Dupuytren’s disease: clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol 53(3):291–296

    Article  PubMed  CAS  Google Scholar 

  • Hart S (2012) A primer of collagen biology: synthesis, degradation, subtypes and role in Dupuytren’s disease. In: Dupuytren’s disease and related hyperproliferative disorders, pp 131–142

    Google Scholar 

  • Hindocha S, John S, Stanley JK, Watson SJ, Bayat A (2006a) The heritability of Dupuytren’s disease: familial aggregation and its clinical significance. J Hand Surg Am 31:204–210

    Article  PubMed  Google Scholar 

  • Hindocha S, Stanley JK, Watson S, Bayat A (2006b) Dupuytren’s diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am 31(10):1626–1634

    Article  PubMed  Google Scholar 

  • Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, CORD I Study Group (2009) Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 361(10):968–979

    Article  PubMed  CAS  Google Scholar 

  • James J, Tubiana R (1952) Dupuytren’s disease. Rev Chir Orthop Reparatrice Appar Mot 38:555–562

    PubMed  CAS  Google Scholar 

  • Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D (2008) Splinting after contracture release for Dupuytren’s contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial. BMC Musculoskelet Disord 9:62

    Article  PubMed  Google Scholar 

  • Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D (2012) Night-time splinting after fasciectomy or dermofasciectomy for Dupuytren’s Contracture a pragmatic, multi-centre, randomized controlled trial. In: Dupuytren’s disease and related hyperproliferative disorders, pp 323–332

    Google Scholar 

  • Jurisic D, Kovic I, Lulic I, Stanec Z, Kapovic M, Uravic M (2008) Dupuytren’s disease characteristics in primorsko-goranska county, croatia. Coll Antropol 32(4):1209–1213

    PubMed  Google Scholar 

  • Keilholz L, Seegenschmiedt MH, Born AD, Sauer R (1997) Radiotherapy in the early stage of Dupuytren’s disease. The indications, technic and long-term results. Strahlenther Onkol 173:27–35

    Article  PubMed  CAS  Google Scholar 

  • Ketchum L (2012) Expanded Dermofasciectomies and full-thickness grafts in the treatment of Dupuytren’s contracture: a 36-year experience. In: Dupuytren’s disease and related hyperproliferative disorders, pp 213–220

    Google Scholar 

  • Ketchum LD, Donahue TK (2000) The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg 25(6):1157–1162

    CAS  Google Scholar 

  • Langemak GE (1907) Zur thiosinaminbehandlung der Dupuytren’schen Faschienkontraktur. Münchener Med Wochenschr 54:1380

    Google Scholar 

  • Larson D, Jerosch-Herold C (2008) Clinical effectiveness of post-operative splinting after surgical release of Dupuytren’s contracture: a systematic review. BMC Musculoskelet Disord 9:104

    Article  PubMed  Google Scholar 

  • McCarthy DM (1992) The long-term results of enzymatic fasciotomy. J Hand Surg Br 17:356

    Article  PubMed  CAS  Google Scholar 

  • McCash CR (1964) The open palm technique in Dupuytren’s contracture. Br J Plast Surg 17:271–280

    Article  PubMed  CAS  Google Scholar 

  • McFarlane RM, McGrouther DA (1990) Complications and their management. In: McFarlane RM, McGrouther DA, Flint M (eds) Dupuytren’s disease: biology and treatment. Churchill Livingstone, Edinburgh, pp 377–382

    Google Scholar 

  • Meyerding HW, Black JR, Broders AC (1941) The etiology and pathology of Dupuytren’s contracture. Surg Gynecol Obstet 72:582–590

    Google Scholar 

  • Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J (2007) Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren’s disease. J Hand Surg 32(2):240–245

    Article  Google Scholar 

  • Moermans JP (1996) Long-term results after segmental aponeurectomy for Dupuytren’s disease. J Hand Surg Br 21(6):797–800

    Article  PubMed  CAS  Google Scholar 

  • Rehman S, Salway F, Stanley JK, Ollier WE, Day P, Bayat A (2008) Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome. J Hand Surg Am 33:359–372

    Article  PubMed  Google Scholar 

  • Rives K, Gelberman R, Smith B, Carney K (1992) Severe ­contractures of the proximal interphalangeal joint in Dupuytren’s disease: results of aprospective trial of operative correction and dynamic extension splinting. J Hand Surg Am 17:1153–1159

    Article  PubMed  CAS  Google Scholar 

  • Ross DC (1999) Epidemiology of Dupuytren’s disease. Hand Clin 15(1):53–62

    PubMed  CAS  Google Scholar 

  • Seegenschmiedt MH, Olschewski T, Guntrum F (2001) Optimization of radiotherapy in Dupuytren’s disease. Initial results of a controlled trial. Strahlenther Onkol 177:74–81

    Article  PubMed  CAS  Google Scholar 

  • Seegenschmiedt MH, Keilholz L, Wielpütz M, Schubert Ch., Fehlauer F (2012) Long-term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Dupuytren’s disease and related hyperproliferative disorders, pp 349–371

    Google Scholar 

  • Smith P, Breed C (1994) Central slip attenuation in Dupuytren’s contracture: a cause of persistent flexion of the proximal interphalangeal joint. J Hand Surg 19(5):840–843

    Article  CAS  Google Scholar 

  • Thurston AJ (2003) Dupuytren’s disease. J Bone Joint Surg Br 85(4):469–477

    Article  PubMed  Google Scholar 

  • Van Rijssen AL, Werker PM (2006) Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg Br 31:498–501

    Article  PubMed  Google Scholar 

  • Van Rijssen AL, Gerbrandy FS, ter Linden H, Klip H, Werker PM (2006) A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J Hand Surg Am 31:717–725

    Article  PubMed  Google Scholar 

  • Van Rijssen AL, Ter Linden H, Werker PMN (2012) 3-year results of first-ever randomised clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. In: Dupuytren’s disease and related hyperproliferative disorders, pp 281–288

    Google Scholar 

  • Watt AJ, Curtin CM, Hentz VR (2010) Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am 35(4):534–539

    Article  PubMed  Google Scholar 

  • Weinzierl G, Flügel M, Geldmacher J (1993) Lack of effectiveness of alternative non-surgical treatment procedures of dupuytren contracture. Chirurg 64:492–494

    PubMed  CAS  Google Scholar 

  • Wilbrand S, Ekbom A, Gerdin B (1999) The sex ratio and rate of reoperation for Dupuytren’s contracture in men and women. J Hand Surg Br 24(4):456–459

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Marieke Dreise very much for her help in translating our original article.

Author information

Authors and Affiliations

  1. Department of Plastic Surgery, Isala Clinics, Zwolle, The Netherlands

    Annet L. van Rijssen

  2. University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    Paul M. N. Werker

Authors
  1. Annet L. van Rijssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul M. N. Werker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annet L. van Rijssen .

Editor information

Editors and Affiliations

  1. The Hand Center, S Old Dixie Highway 1002, Jupiter, 33458, Florida, USA

    Charles Eaton

  2. Strahlenzentrum Hamburg, Langenhorner Chaussee 369, Hamburg, 22419, Germany

    M. Heinrich Seegenschmiedt

  3. Manchester Interdisciplinary Biocentre, Plastic & Reconstructive Surgery, University of Manchester, Princess Street 131, Manchester, M1 7DN, United Kingdom

    Ardeshir Bayat

  4. Faculty of Medicine, Dept. of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, Geneva, 1211, Switzerland

    Giulio Gabbiani

  5. Medical Center, Department of Plastic Surgery, University of Groningen, Hanzeplein 1, Groningen, 9713 GZ, Netherlands

    Paul Werker

  6. Dupuytren e.V., Westerbuchberg 60b, Übersee, 83236, Germany

    Wolfgang Wach

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

van Rijssen, A.L., Werker, P.M.N. (2012). Treatment for Dupuytren’s Disease: An Overview of Options. In: Eaton, C., Seegenschmiedt, M., Bayat, A., Gabbiani, G., Werker, P., Wach, W. (eds) Dupuytren’s Disease and Related Hyperproliferative Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22697-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-22697-7_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-22696-0

  • Online ISBN: 978-3-642-22697-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation